Researchers provide possible new insights into psychiatric disorders such as schizophrenia.
According to researchers, fMRI brain scans may be used to predict a patient's responsiveness to antipsychotic medications.
A new study reports many people with intellectual disabilities are being prescribed antipsychotic medications even though they have no record of mental illness.
According to a new study, antipsychotic medications could increase the risk of death in patients with Parkinson's disease psychosis.
According to a new study, lithium appears to be safe and effective in treating bipolar disorder in children, at least in the short term.
A new study reports people with Alzheimer's disease are more likely to use antipsychotic medications, and for longer periods of time, than the general public.
A new study reports people with treatment resistant schizophrenia appear to have better outcomes when they are switched to clozapine rather than other antipsychotic medications.
Researchers report a blockade of D2 receptors in interneurons can increase acetylcholine signaling above threshold on neighboring neurons, resulting in motor abnormalities.
According to researchers, a mutation in a gene associated with brain development may dispose people to various psychiatric illnesses as it reduces synapse numbers. Lithium may help to restore some of the synapses.
According to researchers, Cannabidiol, an active compound in cannabis plants, could help to alleviate cognitive impairment in people with schizophrenia.
A new study implicates serotonin 2c receptors with metabolic side effects caused by a common class of antipsychotic medications.
A new study reveals some drug combinations may be more beneficial for those with schizophrenia. Researchers found people with schizophrenia who took antidepressants, in combination with other medications, were less likely to be hospitalized for mental health issues than those who started another antipsychotic.
